Roflumilast, a Type 4 phosphodiesterase inhibitor, shows promising adjunctive, host-directed therapeutic activity in a mouse model of tuberculosis

Mariama C. Maiga, Bintou Ahmadou Ahidjo, Mamoudou Maiga, William R. Bishai*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'Roflumilast, a Type 4 phosphodiesterase inhibitor, shows promising adjunctive, host-directed therapeutic activity in a mouse model of tuberculosis'. Together they form a unique fingerprint.

Medicine & Life Sciences